Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02205333
Brief Title: A Phase 1b/2 Safety and Tolerability Study of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies (MEDI6469)

First Submitted : July 18, 2014
First Submitted that Met QC Criteria : July 29, 2014
First Posted : July 31, 2014 (Estimate)

Results First Submitted : March 27, 2017
Results First Submitted that Met QC Criteria : March 27, 2017
Results First Posted : May 8, 2017

Last Update Submitted that Met QC Criteria : June 1, 2017
Last Update Posted : June 28, 2017